Major Vault Protein (MVP) (Middle Region) Peptid
MVP
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle MVP Produkte
- MVP (Major Vault Protein (MVP))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- ELLNKGQDPL ADRGEKDTAK SLQPLAPRNK TRVVSYRVPH NAAVQVYDYR
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-MVP Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MVP (Major Vault Protein (MVP))
- Hintergrund
-
This gene encodes the major component of the vault complex. Vaults are multi-subunit ribonucleoprotein structures that may be involved in nucleo-cytoplasmic transport. The encoded protein may play a role in multiple cellular processes by regulating the MAP kinase, JAK/STAT and phosphoinositide 3-kinase/Akt signaling pathways. The encoded protein also plays a role in multidrug resistance, and expression of this gene may be a prognostic marker for several types of cancer. Alternatively spliced transcript variants have been observed for this gene.
Alias Symbols: MVP,LRP,
Protein Size: 893 - Gen-ID
- 9961
- NCBI Accession
- NP_059447
- UniProt
- Q14764
-
Sie sind hier:
